Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × Duration of Therapy × Clear all

NCT00097929 2017-04-07

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse